» 
Meet Our CMO
Copy URL
https://www.pharmnovo.com/post/meet-our-cmo

Meet Our CMO

October 25, 2021

PharmNovo is pleased to announce the appointment of Olof Breuer MD, PhD, Specialist in Clinical Pharmacology, who will be acting as our Chief medical officer.

Olof has over 25 years of experience in Pharmaceutical R&D, where of 17 years within big and small pharmaceutical companies. He has held positions as medical adviser, principal scientist, project manager and clinical pharmacology director. Areas of expertise span through preclinical R&D, translational sciences, and clinical development, including clinical evaluation of in-licensing opportunities.

As trained pharmacokineticist, he has routinely developed and utilised modelling and simulation techniques to facilitate studydesign and data evaluation. At present, he is based at the Clinical trials unit/Department of clinical pharmacology at Karolinska university hospital.

Latest news

View all
September 5, 2022

OP Team steps up

PharmNovo appoints CFO and Clinical lead to strengthen the organization.

August 19, 2022

Phase I study initiated

We are pleased to inform that during the summer, the application to start

June 3, 2022

67 MSEK in new Founding

We are pleased to announce that we have raised 67 MSEK in a new share issue led by Sciety.

May 30, 2022

The CTA is Submitted

The Clinical Trial Application (CTA) has been submitted to the MPA

← Back
No items found.
October 25, 2021

Meet Our CMO

PharmNovo is pleased to announce the appointment of Olof Breuer MD, PhD, Specialist in Clinical Pharmacology, who will be acting as our Chief medical officer.

Olof has over 25 years of experience in Pharmaceutical R&D, where of 17 years within big and small pharmaceutical companies. He has held positions as medical adviser, principal scientist, project manager and clinical pharmacology director. Areas of expertise span through preclinical R&D, translational sciences, and clinical development, including clinical evaluation of in-licensing opportunities.

As trained pharmacokineticist, he has routinely developed and utilised modelling and simulation techniques to facilitate studydesign and data evaluation. At present, he is based at the Clinical trials unit/Department of clinical pharmacology at Karolinska university hospital.

October 25, 2021

Meet Our CMO

PharmNovo is pleased to announce the appointment of Olof Breuer MD, PhD, Specialist in Clinical Pharmacology, who will be acting as our Chief medical officer.

Olof has over 25 years of experience in Pharmaceutical R&D, where of 17 years within big and small pharmaceutical companies. He has held positions as medical adviser, principal scientist, project manager and clinical pharmacology director. Areas of expertise span through preclinical R&D, translational sciences, and clinical development, including clinical evaluation of in-licensing opportunities.

As trained pharmacokineticist, he has routinely developed and utilised modelling and simulation techniques to facilitate studydesign and data evaluation. At present, he is based at the Clinical trials unit/Department of clinical pharmacology at Karolinska university hospital.

Author:

Petra Larson

Author:

Petra Larson

OP Team steps up

PharmNovo appoints CFO and Clinical lead to strengthen the organization.

Read more →

Phase I study initiated

We are pleased to inform that during the summer, the application to start

Read more →

67 MSEK in new Founding

We are pleased to announce that we have raised 67 MSEK in a new share issue led by Sciety.

Read more →

The CTA is Submitted

The Clinical Trial Application (CTA) has been submitted to the MPA

Read more →
Latest
breaking
news

Find us

PharmNovo AB
Medicon Village AB
Scheeletorget 1
SE-223 81 Lund, Sweden

Map